Skip to main content
Journal cover image

Management of rocuronium neuromuscular block using a protocol for qualitative monitoring and reversal with neostigmine.

Publication ,  Journal Article
Thilen, SR; Ng, IC; Cain, KC; Treggiari, MM; Bhananker, SM
Published in: Br J Anaesth
August 2018

BACKGROUND: Neuromuscular block using subjective monitoring and neostigmine reversal is commonly associated with postoperative residual neuromuscular block. We tested whether a protocol for the management of neuromuscular block that specified appropriate dosing and optimal neostigmine reversal was associated with a reduction in postoperative residual neuromuscular block. METHODS: Rocuronium administration was guided by surgical requirements and based on the ideal body weight, with dose reductions for female sex and age >55 yr. Neostigmine was administered in adjusted doses after a train-of-four count of four was confirmed at the thumb. The protocol ensured a minimum of 10 min between neostigmine administration and tracheal extubation. We measured the postoperative residual neuromuscular block in patients undergoing abdominal surgery before and after introduction of the protocol. Pre-specified primary and secondary endpoints were incidence of postoperative residual neuromuscular block and severe postoperative residual neuromuscular block at the time of tracheal extubation, defined as normalised train-of-four ratios <0.9 and <0.7, respectively. RESULTS: The incidence of postoperative residual neuromuscular block at tracheal extubation was 14/40 (35%) for patients managed according to the protocol compared with 22/38 (58%) for patients in the control group, odds ratio of 0.39, and 95% confidence interval of 0.14-1.07; P=0.068. The incidence of severe postoperative residual neuromuscular block at tracheal extubation showed a highly significant difference, odds ratio=0.06, and confidence interval of 0.00-0.43; P=0.001. CONCLUSIONS: The incidence of severe postoperative residual neuromuscular block was significantly reduced after the protocol was introduced. Given the limitations inherent in this before-and-after study, further research is needed to confirm these results. CLINICAL TRIAL REGISTRATION: NCT02660398.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Br J Anaesth

DOI

EISSN

1471-6771

Publication Date

August 2018

Volume

121

Issue

2

Start / End Page

367 / 377

Location

England

Related Subject Headings

  • Rocuronium
  • Prospective Studies
  • Postoperative Complications
  • Parasympathomimetics
  • Neuromuscular Nondepolarizing Agents
  • Neuromuscular Blockade
  • Neostigmine
  • Muscle Weakness
  • Monitoring, Physiologic
  • Middle Aged
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Thilen, S. R., Ng, I. C., Cain, K. C., Treggiari, M. M., & Bhananker, S. M. (2018). Management of rocuronium neuromuscular block using a protocol for qualitative monitoring and reversal with neostigmine. Br J Anaesth, 121(2), 367–377. https://doi.org/10.1016/j.bja.2018.03.029
Thilen, S. R., I. C. Ng, K. C. Cain, M. M. Treggiari, and S. M. Bhananker. “Management of rocuronium neuromuscular block using a protocol for qualitative monitoring and reversal with neostigmine.Br J Anaesth 121, no. 2 (August 2018): 367–77. https://doi.org/10.1016/j.bja.2018.03.029.
Thilen SR, Ng IC, Cain KC, Treggiari MM, Bhananker SM. Management of rocuronium neuromuscular block using a protocol for qualitative monitoring and reversal with neostigmine. Br J Anaesth. 2018 Aug;121(2):367–77.
Thilen, S. R., et al. “Management of rocuronium neuromuscular block using a protocol for qualitative monitoring and reversal with neostigmine.Br J Anaesth, vol. 121, no. 2, Aug. 2018, pp. 367–77. Pubmed, doi:10.1016/j.bja.2018.03.029.
Thilen SR, Ng IC, Cain KC, Treggiari MM, Bhananker SM. Management of rocuronium neuromuscular block using a protocol for qualitative monitoring and reversal with neostigmine. Br J Anaesth. 2018 Aug;121(2):367–377.
Journal cover image

Published In

Br J Anaesth

DOI

EISSN

1471-6771

Publication Date

August 2018

Volume

121

Issue

2

Start / End Page

367 / 377

Location

England

Related Subject Headings

  • Rocuronium
  • Prospective Studies
  • Postoperative Complications
  • Parasympathomimetics
  • Neuromuscular Nondepolarizing Agents
  • Neuromuscular Blockade
  • Neostigmine
  • Muscle Weakness
  • Monitoring, Physiologic
  • Middle Aged